Have a Claim?

Click here for a confidential contact or call:


February 6, 2019

Posted  February 6, 2019

Abbott Labs has agreed to pay a total of $25 million to settle allegations of paying kickbacks to healthcare professionals in exchange for promotion of its drug, and inappropriately marketing its drug, TriCor, for cardiovascular events not approved by the FDA. The case was initiated by the State of North Carolina and joined by California, Illinois, Nevada, Maryland, Michigan, and Texas, as well as the federal government. NC AG

Tagged in: Anti-Kickback and Stark, Healthcare Fraud, Medicaid, Off-Label and Unapproved Use, Other Government Health Programs, Pharma Fraud,